“Study of Lopinavir/Ritonavir in Severe COVID-19 Patients with Comorbid Hypertension and Diabetes Mellitus”, Indian Journal of Forensic Medicine & Toxicology, vol. 16, no. 4, pp. 174–181, Oct. 2022, doi: 10.37506/ijfmt.v16i4.18570.